In the last trading session, 1.29 million Calidi Biotherapeutics Inc (AMEX:CLDI) shares changed hands as the company’s beta touched 1.15. With the company’s per share price at $1.05 changed hands at -$0.21 or -16.67% during last session, the market valuation stood at $27.21M. CLDI’s last price was a discount, traded about -1500.0% off its 52-week high of $16.80. The share price had its 52-week low at $0.58, which suggests the last value was 44.76% up since then.

Calidi Biotherapeutics Inc (AMEX:CLDI) trade information

Instantly CLDI was in red as seen at the end of in last trading. With action -22.22%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -8.70%, with the 5-day performance at -22.22% in the red. However, in the 30-day time frame, Calidi Biotherapeutics Inc (AMEX:CLDI) is 37.43% up.

The consensus price target for the stock as assigned by Wall Street analysts is 5.5, meaning bulls need an upside of 80.91% from its current market value. According to analyst projections, CLDI’s forecast low is 2 with 9 as the target high. To hit the forecast high, the stock’s price needs a -757.14% plunge from its current level, while the stock would need to soar -90.48% for it to hit the projected low.

Calidi Biotherapeutics Inc (AMEX:CLDI)’s Major holders

CPR INVESTMENTS INC. holds the second largest percentage of outstanding shares, with 1.0511% or 0.56 million shares worth $0.11 million as of 2024-06-30.

Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund. With 92.51 shares estimated at $97139.0 under it, the former controlled 0.33% of total outstanding shares. On the other hand, Fidelity Total Market Index Fund held about 0.11% of the shares, roughly 31.88 shares worth around $33468.0.